Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/09/2008WO2008094912A3 Substituted gamma lactams as therapeutic agents
10/09/2008WO2008094203A3 Polar ester prodrugs of heterocyclic hybrid antibacterial compounds and salts thereof
10/09/2008WO2008092942A3 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators
10/09/2008WO2008091701A3 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
10/09/2008WO2008091686A3 SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
10/09/2008WO2008091555A3 Nuclear receptor binding agents
10/09/2008WO2008091525A8 Anthelmintic macrolactams from nonmuraea turkmeniaca ma 7364
10/09/2008WO2008089008A3 Tetrahydrobiopterin prodrugs
10/09/2008WO2008086188A3 Thiophene carboxamides as factor xa inhibitors
10/09/2008WO2008084081A3 2-substituted 5-phenylpyrimidines for the treatment of proliferative disorders
10/09/2008WO2008082658A3 Cyclitols and their derivatives and their therapeutic applications
10/09/2008WO2008081111A8 OLIGO-β(1→3)-GLUCANES HAVING AN ALLERGIC-REACTION INHIBITING EFFECT AND APPLICATIONS THEREOF
10/09/2008WO2008079521A3 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/09/2008WO2008077062A3 Suppression of stat3 reactivation after src kinase inhibition to treat cancer
10/09/2008WO2008076251A8 Biocidal composition and method for treating recirculating water systems
10/09/2008WO2008074885A3 Process for manufacturing ophthalmic oil-in-water emulsions
10/09/2008WO2008074679A3 4-imidazolines as taar's ligands
10/09/2008WO2008073759A3 An article comprising prasugrel
10/09/2008WO2008070795A3 Combination therapy using low-dose doxepin for the improvement of sleep
10/09/2008WO2008070778A3 Pyridoxamine and low molecular weight heparinoids for diabetic kidney disease
10/09/2008WO2008070354A3 5- and 6- substituted benzimidazole thiophene compounds
10/09/2008WO2008069938A3 Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
10/09/2008WO2008067991A3 Skin-friendly drug complexes for transdermal administration
10/09/2008WO2008065674A8 Preparation of a free flowing molecular dispersion of clopidogrel base
10/09/2008WO2008065444B1 Substituted quinazolines
10/09/2008WO2008064916A3 Agent for treating vascular leaks
10/09/2008WO2008064342A3 Pde10 inhibitors and related compositions and methods
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/09/2008WO2008064096A3 Elongase gene and uses thereof
10/09/2008WO2008062428B1 Novel antimicrobial formulations incorporating alkyl esters of fatty acids and nanoemulsions thereof
10/09/2008WO2008060621A3 Aminopyrrolidines as chemokine receptor antagonists
10/09/2008WO2008059367A8 Penem prodrugs
10/09/2008WO2008058210A3 Local administration of gallium compositions to treat pain
10/09/2008WO2008057252A3 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
10/09/2008WO2008055146A3 Formulations of phospholipase enzyme inhibitors
10/09/2008WO2008054454A3 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
10/09/2008WO2008051594A3 Anti-resorptive and bone building dietary supplements and methods of use
10/09/2008WO2008050301A3 2- phenyl- 6-aminocarbonyl- pyrimidine derivatives and their use as p2y12 receptor antagonists
10/09/2008WO2008049105A3 Sulfamoyl-containing derivatives and uses thereof
10/09/2008WO2008045817A3 Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage
10/09/2008WO2008041933A3 Rna interference against wrap53 to treat hyperproliferative diseases
10/09/2008WO2008039855A3 Nutrient sensor
10/09/2008WO2008039409A3 Methods and kits for use in the treatment and prevention of diseases or conditions of the immune system or infectious diseases
10/09/2008WO2008033807A3 Synergistic combinations of antineoplastic thiol-binding mitochondrial oxidants and antineoplastic proteasome inhibitors for the treatment of cancer
10/09/2008WO2008032105A3 Flavonoid derivatives and their uses
10/09/2008WO2008030836A3 Bcl inhibitors treating platelet excess
10/09/2008WO2008027912A3 Prediction of an agent's or agents' activity across different cells and tissue types
10/09/2008WO2008024983A3 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
10/09/2008WO2008024922A3 8-hydroxyquinoline compounds and methods thereof
10/09/2008WO2008024304A3 Compounds for treatment of proliferative disorders
10/09/2008WO2008024285A3 Antibiotic compound
10/09/2008WO2008022295A3 Prlr-specific antibody and uses thereof
10/09/2008WO2008022242A3 Synthesis of propyl phenoxy ethers and use as delivery agents
10/09/2008WO2008022002A3 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
10/09/2008WO2008021729A3 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
10/09/2008WO2008021728A3 Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents
10/09/2008WO2008021625A3 Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
10/09/2008WO2008021456A3 N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/09/2008WO2008021341A3 Modafinil-based treatment for premature ejaculation
10/09/2008WO2008019212A3 Compositions containing chalcones and use thereof
10/09/2008WO2008019136A3 Transdermal atomoxetine formulations and associated methods
10/09/2008WO2008017025A3 Combination therapy
10/09/2008WO2008016811A3 Aminopiperidines and realted compounds
10/09/2008WO2008015202A3 Anticonvulsive pharmaceutical compositions
10/09/2008WO2008013856A3 Methods and compositions for production, formulation and use of 1 aryl -3-azabicyclo[3.1.0 ] hexanes
10/09/2008WO2008007262B1 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
10/09/2008WO2008002582A3 Ultraviolet absorbing ophthalmic compositions
10/09/2008WO2008002245A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2008002244A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2008001306B1 Streptomycete and bioactive compound produced thereby
10/09/2008WO2007131041A3 The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
10/09/2008WO2007127393A3 Treatment and screening methods for promoting neurogenesis
10/09/2008WO2007124424A3 Il-8 receptor antagonists
10/09/2008WO2007120575A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/09/2008WO2007117699A3 Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-87877, nsc-117199 and their analogs
10/09/2008WO2007112457A3 Aprepitant polymorph mixtures
10/09/2008WO2007112001A3 Compositions and methods for treating myocardial infarction
10/09/2008WO2007100728A3 Mannose derivatives for killing tumor cells
10/09/2008WO2007100663A3 Polyamines and their use as antibacterial and sensitizing agents
10/09/2008WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression
10/09/2008WO2007092721A8 Vitamin d analog: rak, methods and uses thereof
10/09/2008WO2007092285A3 Treatment of synucleinopathies
10/09/2008WO2007089367A3 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer
10/09/2008WO2007088214A3 Treating hiv infection, wherein hiv has a k65r mutation
10/09/2008WO2007086943A3 Wortmannin conjugates and uses thereof
10/09/2008WO2007084419A3 Inhibition of inflammatory cytokine production with tanshinones
10/09/2008WO2007081542A9 Tetralone-based monoamine reuptake inhibitors
10/09/2008WO2007018660A3 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits
10/09/2008WO2006116423A3 Compositions and methods for cancer immunotherapy
10/09/2008WO2006074117A3 Silver/water, silver gels and silver-based compositions; and methods for making and using the same
10/09/2008WO2006030301A8 Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers
10/09/2008WO2005099721A3 Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
10/09/2008US20080249322 Processes for preparing crystalline and amorphous mupirocin calcium
10/09/2008US20080249320 Luminacin analogs and uses thereof
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249188 Methods and devices for non-invasive cerebral and systemic cooling
10/09/2008US20080249187 Skin Sanitizing Antimicrobial Alcoholic Compositions
10/09/2008US20080249185 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs
10/09/2008US20080249184 Methods for modulating neuronal cell death
10/09/2008US20080249183 Treatment of androgen-deprivation induced osteoporosis
1 ... 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 ... 7860